HUM vs SRPT · P/E 39, rev $117.76B vs rev $1.90B
Humana Inc (HUM) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the HUM and SRPT stock pages for the full models.
Not investment advice.